Dose-modifying factor for captopril for mitigation of radiation injury to normal lung
Dose-modifying factor for captopril for mitigation of radiation injury to normal lung
About this item
Full title
Author / Creator
Publisher
England: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
England: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Our goal is to develop countermeasures for pulmonary injury following unpredictable events such as radiological terrorism or nuclear accidents. We have previously demonstrated that captopril, an angiotensin converting enzyme (ACE) inhibitor, is more effective than losartan, an angiotensin type-1 receptor blocker, in mitigating radiation-pneumopathy...
Alternative Titles
Full title
Dose-modifying factor for captopril for mitigation of radiation injury to normal lung
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3393339
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3393339
Other Identifiers
ISSN
0449-3060
E-ISSN
1349-9157
DOI
10.1093/jrr/rrs004
